Skip to main content

Table 1 Patient demographics a

From: Assessing THK523 selectivity for tau deposits in Alzheimer’s disease and non–Alzheimer’s disease tauopathies

Diagnosis

No. of patients

Mean age (SD), years

Mean PMI (hours)

AD

3

72.9 ± 6.7

22.8 ± 8.8

PSP

3

73.2 ± 4.6

37.2 ± 18.6

PiD

2

75.4 ± 7.1

47.0 ± 5.2

CBD

1

72.5

11.0

PD

1

70.5

22.5

  1. aAD, Alzheimer’s disease; CBD, Corticobasal degeneration; PD, Parkinson’s disease; PiD, Pick’s disease; PMI, Postmortem interval; PSP, Progressive supranuclear palsy.